{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:05:45Z","timestamp":1770249945344,"version":"3.49.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      [\n                      <jats:sup>18<\/jats:sup>\n                      F]fluoro-2-deoxy-D-glucose ([\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG)-PET\/MRI is a \u2018one-stop-shop\u2019 combination that enriches lesion characterization, locoregional and distant staging in breast cancer patients. The combination consists of a breast (bpPET\/MRI) and whole-body (wbPET\/MRI) within a single protocol. Despite acceptable test-retest reproducibility of standardized uptake value (SUV) in PET examinations being 10%, limited knowledge concerning agreement between metabolic parameters from each protocol (bpPET\/MRI and wbPET\/MRI) is available.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Feasibility study to verify whether differences of metabolic parameters in breast tumor, on prone bpPET\/MRI acquired between 30 and 55 min postinjection, and compared to wbPET\/MRI at 60 min, remained within the 10% margin acceptable in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Breast cancer patients underwent [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/MRI: bpPET\/MRI and wbPET\/MRI. Maximum SUV (SUVmax) and mean SUV (SUVmean) measurements of the index tumor, contralateral breast, liver, and blood pool were obtained from bpPET\/MRI images acquired every 5 min between 30 and 55 min. These values were compared with wbPET\/MRI SUVs at 60 min (reference).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty patients were included. The majority of PET\/MRI exams remained within the 10% margin at all timepoints. At 45 and 50 min the mean percentage difference of SUVmax and SUVmean compared to 60 min was less than 1.3\u20133.6%. Other SUV measurements remained within 10% margin in majority of cases, while bloodpool SUVs did differ.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Metabolic parameters for local staging in the index tumor on bpPET\/MRI may be considered comparable to the metabolic parameters retrieved from wbPET\/MRI in breast cancer patients. These findings reinforce the potential of a breast-dedicated protocol integrated in the whole-body [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG PET\/MRI in breast cancer patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002091","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:03:17Z","timestamp":1764835397000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic parameters on [18F]fluoro-2-deoxy-d-glucose PET\/MRI: feasibility study comparing standardized uptake value quantification obtained from dedicated breast and whole-body scans within a single protocol in breast cancer patients"],"prefix":"10.1097","volume":"47","author":[{"given":"Iris","family":"van Elferen","sequence":"first","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia Carrilho","family":"Vaz","sequence":"additional","affiliation":[{"name":"Nuclear Medicine-Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal"},{"name":"Department of Radiology, Leiden University Medical Center, Leiden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patty J.","family":"Nelemans","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Maastricht University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roel","family":"Wierts","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tineke","family":"van de Weijer","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands"},{"name":"NUTRIM, School of Nutrition and Translational Research in Metabolism"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein L.","family":"Smidt","sequence":"additional","affiliation":[{"name":"GROW \u2013 Research institute for Oncology and Reproduction, Maastricht University"},{"name":"Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix M.","family":"Mottaghy","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands"},{"name":"GROW \u2013 Research institute for Oncology and Reproduction, Maastricht University"},{"name":"Department of Nuclear Medicine, University Hospital, RWTH Aachen University, Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-3538","authenticated-orcid":false,"given":"Thiemo J.A.","family":"van Nijnatten","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands"},{"name":"GROW \u2013 Research institute for Oncology and Reproduction, Maastricht University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"R1-20260204","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260204","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s00259-024-06696-9","article-title":"Joint EANM-SNMMI guideline on the role of 2-[(18)F]FDG PET\/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI\/ESR, and EUSOMA).","volume":"51","author":"Vaz","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-20260204","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/MNM.0000000000001254","article-title":"Diagnostic performance of PET\/computed tomography versus PET\/MRI and diffusion-weighted imaging in the N- and M-staging of breast cancer patients.","volume":"41","author":"de Mooij","year":"2020","journal-title":"Nucl Med Commun"},{"key":"R4-20260204","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer.","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann Oncol"},{"key":"R6-20260204","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00330-017-5121-4","article-title":"A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice.","volume":"28","author":"Clauser","year":"2018","journal-title":"Eur Radiol"},{"key":"R7-20260204","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.semnuclmed.2022.01.003","article-title":"A role of PET\/MR in breast cancer?","volume":"52","author":"Bruckmann","year":"2022","journal-title":"Semin Nucl Med"},{"key":"R8-20260204","doi-asserted-by":"crossref","first-page":"9953","DOI":"10.2147\/CMAR.S252801","article-title":"Breast cancer brain metastasis: the potential role of MRI beyond current clinical applications.","volume":"12","author":"Hadjipanteli","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R9-20260204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/diagnostics8030045","article-title":"Whole-body MRI with diffusion-weighted imaging in bone metastases: a narrative review.","volume":"8","author":"Stecco","year":"2018","journal-title":"Diagnostics (Basel)"},{"key":"R10-20260204","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00330-018-5720-8","article-title":"What is the diagnostic performance of 18-FDG-PET\/MR compared to PET\/CT for the N- and M- staging of breast cancer?","volume":"29","author":"Botsikas","year":"2019","journal-title":"Eur Radiol"},{"key":"R11-20260204","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/bjc.2015.112","article-title":"Comparison of CE-FDG-PET\/CT with CE-FDG-PET\/MR in the evaluation of osseous metastases in breast cancer patients.","volume":"112","author":"Catalano","year":"2015","journal-title":"Br J Cancer"},{"key":"R12-20260204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1148\/radiol.2016151155","article-title":"Comparison of whole-body (18)F FDG PET\/MR imaging and whole-body (18)F FDG PET\/CT in terms of lesion detection and radiation dose in patients with breast cancer.","volume":"281","author":"Melsaether","year":"2016","journal-title":"Radiology"},{"key":"R13-20260204","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.3390\/cancers13143571","article-title":"PET\/MRI for staging the axilla in breast cancer: current evidence and the rationale for SNB vs. PET\/MRI trials.","volume":"13","author":"Di Micco","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R14-20260204","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S1470-2045(21)00577-5","article-title":"Clinical advances in PET-MRI for breast cancer.","volume":"23","author":"Fowler","year":"2022","journal-title":"Lancet Oncol"},{"key":"R15-20260204","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jmri.28431","article-title":"Breast PET\/MRI hybrid imaging and targeted tracers.","volume":"57","author":"Romeo","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"R16-20260204","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.semnuclmed.2022.02.005","article-title":"The Clinical value of breast specific gamma imaging and positron imaging: an update.","volume":"52","author":"Hatazawa","year":"2022","journal-title":"Semin Nucl Med"},{"key":"R17-20260204","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13139-016-0446-5","article-title":"Potential clinical applications of (18)F-Fluorodeoxyglucose positron emission tomography\/magnetic resonance mammography in breast cancer.","volume":"51","author":"Cho","year":"2017","journal-title":"Nucl Med Mol Imaging"},{"key":"R18-20260204","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13244-024-01830-5","article-title":"[(18)F]FDG whole-body PET-MR including an integrated breast MR protocol for locoregional and distant staging in breast cancer patients-a feasibility study.","volume":"15","author":"van Nijnatten","year":"2024","journal-title":"Insights Imaging"},{"key":"R20-20260204","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2967\/jnumed.118.209544","article-title":"Test-Retest Reproducibility of (18)F-FDG PET\/CT uptake in cancer patients within a qualified and calibrated local network.","volume":"60","author":"Kurland","year":"2019","journal-title":"J Nucl Med"},{"key":"R21-20260204","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy.","volume":"31","author":"Kinahan","year":"2010","journal-title":"Semin Ultrasound CT MR"},{"key":"R22-20260204","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2967\/jnumed.118.218735","article-title":"Measurement repeatability of (18)F-FDG PET\/CT Versus (18)F-FDG PET\/MRI in solid tumors of the Pelvis.","volume":"60","author":"Fraum","year":"2019","journal-title":"J Nucl Med"},{"key":"R23-20260204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40644-017-0113-9","article-title":"Reproducibility and repeatability of same-day two sequential FDG PET\/MR and PET\/CT.","volume":"17","author":"Groshar","year":"2017","journal-title":"Cancer Imaging"},{"key":"R24-20260204","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00259-017-3853-7","article-title":"EANM\/EARL FDG-PET\/CT accreditation - summary results from the first 200 accredited imaging systems.","volume":"45","author":"Kaalep","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-20260204","doi-asserted-by":"crossref","first-page":"100006","DOI":"10.1016\/j.eanmj.2025.100006","article-title":"[18F]FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 3.0.","volume":"1","author":"Boellaard","year":"2025","journal-title":"EANM J"},{"key":"R27-20260204","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00259-023-06406-x","article-title":"International EANM-SNMMI-ISMRM consensus recommendation for PET\/MRI in oncology.","volume":"50","author":"Veit-Haibach","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R29-20260204","doi-asserted-by":"crossref","first-page":"e0192549","DOI":"10.1371\/journal.pone.0192549","article-title":"Use of count-based image reconstruction to evaluate the variability and repeatability of measured standardised uptake values.","volume":"13","author":"Kaneta","year":"2018","journal-title":"PLoS One"},{"key":"R30-20260204","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40658-022-00470-2","article-title":"Method to determine the statistical technical variability of SUV metrics.","volume":"9","author":"De Luca","year":"2022","journal-title":"EJNMMI Physics"},{"key":"R31-20260204","doi-asserted-by":"crossref","first-page":"e13122","DOI":"10.1097\/MD.0000000000013122","article-title":"Impacts of time interval on 18F-FDG uptake for PET\/CT in normal organs: a systematic review.","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R32-20260204","first-page":"415","article-title":"Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors.","volume":"369","author":"Yamaguchi","year":"1986","journal-title":"Acta Radiol Suppl"},{"key":"R33-20260204","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18383\/j.tom.2015.00151","article-title":"Effect of (18)F-FDG uptake time on lesion detectability in PET imaging of early stage breast cancer.","volume":"1","author":"Wangerin","year":"2015","journal-title":"Tomography"},{"key":"R34-20260204","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1102\/1470-7330.2008.0010","article-title":"Predictive and prognostic value of FDG-PET.","volume":"8","author":"Geus-Oei","year":"2008","journal-title":"Cancer Imaging"},{"key":"R35-20260204","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2967\/jnumed.123.266331","article-title":"Promising candidate prognostic biomarkers in [18F]FDG PET images: evaluation in independent cohorts of non-small cell lung cancer patients.","volume":"65","author":"Hovhannisyan-Baghdasarian","year":"2024","journal-title":"J Nucl Med"},{"key":"R36-20260204","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/diagnostics12020451","article-title":"Influences on PET quantification and interpretation.","volume":"12","author":"Rogasch","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R37-20260204","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3390\/cancers15102715","article-title":"18F-FDG PET-derived volume-based parameters to predict disease-free survival in patients with grade III breast cancer of different molecular subtypes candidates to neoadjuvant chemotherapy.","volume":"15","author":"Quartuccio","year":"2023","journal-title":"Cancers"},{"key":"R38-20260204","doi-asserted-by":"crossref","first-page":"13409","DOI":"10.3390\/ijms232113409","article-title":"PET-derived radiomics and artificial intelligence in breast cancer: a systematic review.","volume":"23","author":"Urso","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"R39-20260204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00259-017-3740-2","article-title":"EANM\/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.","volume":"44","author":"Aide","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R40-20260204","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2967\/jnumed.115.158402","article-title":"Summary of the UPICT protocol for 18F-FDG PET\/CT imaging in oncology clinical trials.","volume":"56","author":"Graham","year":"2015","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:00:35Z","timestamp":1770202835000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002091","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"2025-10-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}